Pharmaceuticals

Global Follicle Stimulating Hormone Market Valuation and Growth Prospects: $2.59 Billion by 2029

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the follicle stimulating hormone market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Follicle Stimulating Hormone Market Size?

The follicle stimulating hormone market size has seen a steady increase in recent years. It is anticipated to expand from $2.03 billion in 2024 to $2.12 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.4%. The historical rise in this market can be attributed to the increased occurrence of hormonal disorders, a growing need for fertility treatment, the expansion of FSH indications, the entry of new FSH products into the market, and an increasing demand for safe and effective contraceptive options.

The follicle stimulating hormone market is projected to experience substantial expansion in the coming years, reaching $2.59 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.2%. This growth over the forecast period is primarily attributed to factors such as widening therapeutic applications, an increasing demand for combination therapy, a growing need for effective contraceptive options, the healthcare requirements of an aging population, and market expansion into key regions. Prominent trends anticipated during this period include the development of advanced biosimilar FSH products, regulatory approvals and improved market access, technological advancements in FSH production and delivery, and the continuous need for effective contraceptive options.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12486&type=smp

What Core Market Drivers Are Expanding The Follicle Stimulating Hormone Industry?

The rising incidence of infertility is anticipated to fuel expansion in the follicle-stimulating hormone market. This condition, characterized by the inability to achieve pregnancy after 12 months or more of regular, unprotected intercourse, impacts the reproductive systems of both males and females. In females, follicle-stimulating hormone stimulates egg maturation within the ovaries and assists in governing the menstrual cycle. For men, it fosters testicular development and contributes to the production of a crucial protein for male fertility by encouraging the formation of healthy sperm. As an illustration, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported in April 2023 that approximately 1 in 6 adults globally, or roughly 17.5% of the adult population, experienced infertility. Additionally, the Australian Bureau of Statistics, an Australia-based self-governing constitutional body responsible for data collection and analysis to inform government recommendations, indicated in October 2023 that 300,684 births were registered in 2022, marking a 3% decrease from 2021. The average fertility rate across all Australian women stood at 1.63 births per woman. Consequently, the rising occurrence of infertility is a key factor propelling the expansion of the follicle-stimulating hormone market.

What Segment Insights Are Highlighted In The Follicle Stimulating Hormone Market Report?

The follicle stimulating hormone market covered in this report is segmented –

1) By Type: Recombinant FSH, Urinary FSH

2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications

3) By End-Users: Infertility Center, Hospitals, Other End-Users

Subsegments:

1) By Recombinant FSH: Pure Recombinant FSH, Mixed Recombinant FSH Formulations

2) By Urinary FSH: Purified Urinary FSH, Urinary FSH Combined With Other Hormones

Which Notable Trends Are Transforming The Follicle Stimulating Hormone Market Outlook?

Product innovations are a prominent trend increasing in popularity within the follicle-stimulating hormone market. Major companies operating in this market are concentrating on creating innovative products to strengthen their presence. For instance, in July 2024, Proov, a US-based women’s health company, launched the Proov Empower Perimenopause Testing System. Proov Empower delivers comprehensive and tailored insights into how a woman’s changing hormones impact her overall health and wellness. This non-invasive, multi-time point urine test quantifies four key hormones—FSH, estrogen marker E1G, progesterone marker PdG, and LH—that affect symptoms and the perimenopause experience. By providing periodic retesting, Proov Empower helps women monitor hormone fluctuations and symptoms, serving as an important guide during the transition to menopause.

Which Firms Are Driving Innovation Within The Follicle Stimulating Hormone Market?

Major companies operating in the follicle stimulating hormone market include Pfizer Inc., Novartis AG, Abbott Laboratories, Sanofi S.A., Boehringer Ingelheim GmbH, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Emcure Pharmaceuticals Ltd., LG Chem’s life sciences, IBSA Group, Bharat Serums and Vaccines Limited, Anhui Anke Biotechnology Group Co. Ltd., Taj Pharmaceuticals Ltd., Genpharm Inc., Cadwell Laboratories Inc., Creative BioMart, Lee Biosolutions Inc., Trumac Healthcare, Midas Pharma GmbH, Biogenix Inc. Pvt. Ltd., Shanghai Techwell Biopharmaceutical Co. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/follicle-stimulating-hormone-global-market-report

What Regional Trends Are Shaping Growth In The Follicle Stimulating Hormone Market?

North America was the largest region in the follicle stimulating hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12486&type=smp

Browse Through More Reports Similar to the Global Follicle Stimulating Hormone Market 2025, By The Business Research Company

Hormone Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Parathyroid Hormones Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Biosimilar Hormone Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795